--- title: "TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX" type: "News" locale: "en" url: "https://longbridge.com/en/news/296122272.md" description: "Kahn Swick & Foti, LLC has initiated an investigation into TransMedics Group, Inc. (TMDX) regarding potential breaches of fiduciary duty by its officers and directors or violations of state and federal laws. This follows a report by Scorpion Capital alleging fraudulent billing and other misconduct, which led to an ongoing securities class action lawsuit against the company and certain executives." datetime: "2026-08-17T14:39:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296122272.md) - [en](https://longbridge.com/en/news/296122272.md) - [zh-HK](https://longbridge.com/zh-HK/news/296122272.md) generator: "portal-rs" --- # TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into TransMedics Group, Inc. (NasdaqGM: TMDX) (“TransMedics” or the “Company”). TransMedics is a medical technology company focused on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure. The Company operates the Organ Care System, or OCS, and the National OCS Program, or NOP. On January 10, Scorpion Capital released a report alleging that, based on a “6-month investigation with over 30 interviews, including ex-employees, surgeons, leading transplant centers, organ procurement organizations, competitors, and its largest customers,” the Company had engaged in fraudulent billing, coercive business practices, and unsafe organ transplantation, as well as extortion, racketeering, and organ trafficking under the guise of a medical device company. Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period in violation of federal securities laws, which remains ongoing. KSF’s investigation is focusing on whether TransMedics’ officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws. If you have information that would assist KSF in its investigation, or have been a long-term holder of TransMedics shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-538-3606 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgm-tmdx/ to learn more. About Kahn Swick & Foti, LLC KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg. TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services To learn more about KSF, you may visit www.ksfcounsel.com. CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn Kahn Swick & Foti, LLC Lewis Kahn, Managing Partner lewis.kahn@ksfcounsel.com 1-833-538-3606 1100 Poydras St., Suite 960 New Orleans, LA 70163 View source version on businesswire.com: https://www.businesswire.com/news/home/20260817649788/en/ ### Related Stocks - [TMDX.US](https://longbridge.com/en/quote/TMDX.US.md) ## Related News & Research - [07:45 ETRosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX](https://longbridge.com/en/news/296613617.md) - [09:55 ETRosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX](https://longbridge.com/en/news/296239635.md) - [Is TransMedics Group (TMDX) Fairly Valued As Revenue Grew And 2026 Guidance Was Raised?](https://longbridge.com/en/news/296030563.md) - [Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?](https://longbridge.com/en/news/296066899.md) - [TransMedics Targets $2B Opportunity With Kidney Push, European Expansion](https://longbridge.com/en/news/296178365.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**